rs368719191
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_201596.3(CACNB2):c.427G>A(p.Glu143Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000248 in 1,613,932 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_201596.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNB2 | ENST00000324631.13 | c.427G>A | p.Glu143Lys | missense_variant | Exon 4 of 14 | 1 | NM_201596.3 | ENSP00000320025.8 | ||
CACNB2 | ENST00000377329.10 | c.265G>A | p.Glu89Lys | missense_variant | Exon 3 of 13 | 1 | NM_201590.3 | ENSP00000366546.4 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152140Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000398 AC: 10AN: 251322Hom.: 0 AF XY: 0.0000442 AC XY: 6AN XY: 135828
GnomAD4 exome AF: 0.0000239 AC: 35AN: 1461792Hom.: 0 Cov.: 31 AF XY: 0.0000261 AC XY: 19AN XY: 727210
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152140Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74308
ClinVar
Submissions by phenotype
not provided Uncertain:2
The CACNB2 p.Glu88Lys variant was not identified in the literature but was identified in dbSNP (ID: rs368719191), Cosmic, LOVD 3.0 and ClinVar (classified as a VUS by Biesecker Lab/Human Development Section, National Institutes of Health and Illumina for Brugada Syndrome). The variant was identified in control databases in 11 of 282722 chromosomes at a frequency of 0.000039 (Genome Aggregation Database Feb 27, 2017). The variant was observed in the following populations: Ashkenazi Jewish in 4 of 10368 chromosomes (freq: 0.000386), African in 1 of 24972 chromosomes (freq: 0.00004), European (non-Finnish) in 5 of 129064 chromosomes (freq: 0.000039), and South Asian in 1 of 30612 chromosomes (freq: 0.000033), but not in the Latino, East Asian, European (Finnish) or Other populations. The p.Glu88 residue is conserved in mammals but not in more distantly related organisms however computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) provide inconsistent predictions regarding the impact to the protein. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. -
- -
Brugada syndrome 4 Uncertain:1
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt CACNB2 protein function. ClinVar contains an entry for this variant (Variation ID: 191432). This variant has not been reported in the literature in individuals affected with CACNB2-related conditions. This variant is present in population databases (rs368719191, gnomAD 0.04%). This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 89 of the CACNB2 protein (p.Glu89Lys). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at